David Place
10PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers.Fei Tang, Rebecca Kunder, Tom Chu
|Nov 12, 2021
Integrated stress response restricts macrophage necroptosis.David E Place, Parimal Samir, Rk Subbarao Malireddi
|Jun 19, 2021
TLR and IKK Complex-Mediated Innate Immune Signaling Inhibits Stress Granule Assembly.Parimal Samir, David E Place, R K Subbarao Malireddi
|May 05, 2021
Differential Immune Response Following Intranasal and Intradermal Infection with Francisella tularensis: Implications for Vaccine Development.McKayla J Nicol, David R Williamson, David E Place
|Jan 22, 2021
Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins.David E Place, R K Subbarao Malireddi, Jieun Kim
|Dec 03, 2020
Galactosaminogalactan activates the inflammasome to provide host protection.Benoit Briard, Thierry Fontaine, Parimal Samir
Pageof 2
Frequent Collaborators
7 joint publications
Thirumala-Devi Kanneganti
3 joint publications
Parimal Samir
2 joint publications
Rajendra Karki
2 joint publications
R K Subbarao Malireddi
2 joint publications
Peter Vogel
1 joint publications
Benoit Briard
1 joint publications
Shelbi Christgen
1 joint publications
Bernard Henrissat
1 joint publications
Ravi C Kalathur
1 joint publications
Cam Robinson
